As the American Society for Radiation Oncology (ASTRO) concludes today at the Moscone Center in San Francisco, Molecular Imaging caught up with two experts in proton therapy technology and policy—David C. Beyer, MD, president-elect of ASTRO, and Sameer R. Keole, MD, vice chair of ASTRO’s government relations council and a radiation oncologist at the Mayo Clinic in Phoenix—to talk about how this cutting-edge technology is changing.

Two is better than one. At least that may prove to be the case with hybrid approaches that combine PET’s ability to assess myocardial blood flow with other modalities for diagnosing coronary artery disease.

A number of factors are standing out as promoters for and protectors against the development of Alzheimer’s disease, according to research presented during the 2014 Alzheimer’s Association International Conference (AAIC) that was held July 12-17 at the Bella Center in Copenhagen, Denmark.

The challenge was delivered with stark clarity. “We need to establish a new approach to make it easy and affordable for our faculty to quickly transition their imaging probe research from cells and what they see in animal models into human subjects.

As the 2014 Annual Meeting for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) came to a close this year in St. Louis, Molecular Imaging Insight sat down with Barry A. Siegel, MD, professor of radiology and medicine and chief of the nuclear medicine division at local Washington University School of Medicine. 

There are a number of perennial destinations for the molecular imaging set that deliver cutting-edge research and promote clinical discussion, but, for many clinicians and researchers, the Society of Nuclear Medicine and Molecular Imaging’s Annual Meeting is the one conference they attend all year.

Advanced low-grade non-Hodgkin lymphoma (NHL) typically leads to relapse and death in patients who undergo conventional chemo and radiation therapies, but the emergence of radioimmunotherapy (RIT) in recent years has provided an encouraging alternative.

Hyperpolarized MRI, also known as hyperpolarized MRSI (or HP-MRSI), is a new technique representing a major development in molecular MR currently making the rounds in the international molecular imaging circuit.